ERBB2 and breast cancer: Triple-negative breast cancer (TNBC) is an aggressive sub-type of breast cancer that lacks the expression of the hormone receptors (HR) estrogen and progesterone, as well as over-expression of human epidermal growth factor receptor 2 (HER2).